Efficacy and safety of oxaliplatin-based chemotherapy as first-line treatment in elderly patients with metastatic colorectal cancer: a meta-analysis.

Front Oncol · 2025 · PMC12009691 · PMID 40260292

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although the results for OS and PFS did not reach statistical significance, oxaliplatin-based combination therapy demonstrated significant improvements in ORR, CR, PR, and DCR.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.